$CTMX

CytomX Therapeutics, Inc.

Runway:3 mo

NasdaqMarket cap: —CIK 0001501989

Upcoming catalysts

0 surfaced

No catalysts surfaced for CTMX yet.

Drug pipeline

CX-2051

Solid Tumor, Adult

CX-2029

Solid Tumor, Adult

CX-904

Solid Tumors

CX-072

Solid Tumor

CX-2009

Solid Tumor, Adult

CX-801

Solid Tumor, Adult

CX-188

Solid Tumor, Adult

Recent & active trials

NCT	Drug	Phase	Status	Primary completion
NCT06462794	CX-801	Phase 1	Recruiting	2028-02-28
NCT06265688	CX-2051	Phase 1	Recruiting	2027-11-30
NCT05387265	CX-904	Phase 1	Terminated	2025-06-04
NCT04596150	CX-2009	Phase 2	Completed	2023-06-02
NCT03543813	CX-2029	Phase 2	Completed	2023-06-01
NCT03706274	CX-188	Phase 1	Withdrawn	2020-12-01
NCT03013491	CX-072	Phase 2	Terminated	2020-10-27
NCT03149549	CX-2009	Phase 2	Terminated	2020-09-10
NCT03993379	CX-072	Phase 2	Terminated	2020-05-21